Cite
HARVARD Citation
Kumar, D. et al. (2022). Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. Lancet infectious diseases. 22 (5), pp. 718-730. [Online].